Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY
Milestone Scientific reported preliminary Q2 2026 revenue of approximately $2.8 million, a 21% increase from $2.3 million in the prior year, with first-half revenue reaching $5.0 million. The medical segment drove significant momentum with 300% year-over-year growth, supplemented by $500,000 in upside from international orders.
Key figures
- Revenue
- 2800000
- Revenue Yoy
- 21%
- 1h revenue
- $5.0 million
- 1h revenue yoy
- 9%
- International upside
- $500,000
- Base business revenue
- $2.4 million
- Medical segment growth
- 300%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.